<DOC>
	<DOCNO>NCT02389179</DOCNO>
	<brief_summary>Much research vitamin D status focus seasonal variation serum 25 ( OH ) D level population live high altitude light-skinned Caucasian extraction , little work do multi ethnic population live closer equator regard Vitamin supplementation , prevalence , predictor association hypovitaminosis D - assumption , perhaps vitamin D deficiency unlikely location plentiful sunshine . There dearth study Vitamin D status group subject especially high risk falls/fractures i.e . post-menopausal woman osteoporosis live South-East Asia . It possible difference geography ethnicity/culture amongst woman post menopausal osteoporosis ( PMO ) Malaysia may necessitate supplemental Vitamin D dose differ prescribed North American Caucasians . There unified consensus dose Vitamin D supplementation . Neither agreement definition sufficiency researcher target level serum 25 ( OH ) D &gt; 20ng/ml others aim level 30ng/ml . The Institute Medicine ( IOM ) 2010 guideline , aim low serum 25 ( OH ) D target 20ng/ml , advocate maintenance dose 600 IU/day Postmenopausal woman age 51-70 800 IU/day age &gt; 70 year . On contrary , Endocrine Society 2011 guideline state maintenance dose 1500-2000 IU/day may require attain high optimal target &gt; 30ng/ml . On addition , 2014 National Osteoporosis Foundation Guidelines recommend Vitamin D level bring approximately 30ng/ml , maintain level take account limit sun exposure , obese dark skin individual , daily requirement range 800-2000 IU/day . The investigator therefore design prospective randomize control trial compare efficacy safety low ( 900 IU/day ) high ( 1800IU/day 3300IU/day ) maintenance dose Cholecalciferol ( Vitamin D3 ) amongst community dwell Indian Malay PMO live Kuala Lumpur , Malaysia . Hypothesis study despite abundant exposure sunlight , main Vitamin D supplier , dress conservatively individual darker skin may require high dose Vitamin D maintain sufficiency ( &gt; 30ng/ml ) .</brief_summary>
	<brief_title>Determination Vitamin D Dose Maintain Sufficiency Amongst Indian Malay Women Tropics</brief_title>
	<detailed_description>This randomize controlled trial evaluate appropriate dose Vitamin D require maintain Vitamin D sufficiency amongst Indian Malay PMO woman . The study last six month . 150 PMO woman Indian Malay ethnicity randomly allocate 3 different dose regimen i.e . ( ) 25 000 IU/monthly ( ≈900 IU/day ) , ( b ) 50 000 IU/monthly ( ≈1800 IU/day ) ( c ) 50 000 IU/fortnightly ( ≈3300 IU/day ) . Each group contain equal amount Indian Malay Individuals . Subjects recruit osteoporosis clinic UMMC . Inclusion Criteria 1 . Post menopausal Osteoporosis woman receive treatment Osteoporosis Clinic , University Malaya Medical Centre , Kuala Lumpur . 2 . Resident Malaysia , South Indian descent Muslim Malay wear headscarf 3 . Baseline serum 25 ( OH ) D level &gt; 20 ng/ml 50 nmol/L Exclusion Criteria 1 . Secondary osteoporosis e.g . glucocorticoid induce osteoporosis 2 . Metabolic bone disease e.g . hypercalcaemia , primary hyperparathyroidism , hyperthyroidism , hypothyroidism , Paget 's disease 3 . Medications interfere bone / vitamin D metabolism e.g . hormone replacement therapy ( HRT ) , Recombinant human parathyroid hormone i.e . Teriparatide , glucocorticoid , rifampicin anticonvulsant 4 . Calculated Creatinine Clearance &lt; 60 mls/min 5 . Liver disease Malabsorptive Diseases e.g . celiac disease , radiation , enteritis , active inflammatory bowel disease 6 . Malignancy All patient fulfils inclusion exclusion criterion offer participation study write consent obtain . During first visit blood sample take relevant data obtain via interview questionnaire . Blood sample take include total 25 ( OH ) D , calcium , phosphate , albumin PTH level well full blood count , renal liver function . Twenty-four hour urine calcium level also measure . A detailed past medical history medication history focus use bone-related therapy take . Subjects request record medication could affect vitamin D metabolism , e.g . glucocorticoid , Recombinant human parathyroid hormone i.e . Teriparatide , Hormone Replacement Therapy , Rifampicin anticonvulsant . All calcium , vitamin D multivitamin supplement take within 3 month prior clinic visit also record . Von Luschan scale use determine skin colour group patient belongs . This scale contain 36 opaque glass tile compare subject 's skin back hand . A validated sun exposure questionnaire evaluate amongst thing time spend outdoors with/without sun protection , body part expose sun travel sunny area ; fill help train interviewer . Subsequently , rule nine use calculate skin sun exposure . This number multiply reported average sun exposure per week without sunscreen calculate sun exposure index . The subject 's recent dual x-ray absorptiometry result record . All patient receive advice optimal sun exposure ( 10-20 minute sun exposure daily without sun block depend gradation skin colour ) dietary calcium requirement ( 1000 mg/day elemental calcium ) treatment osteoporosis . A detailed diet history focus food high Vitamin D calcium validate questionnaire obtain . Subjects 25 ( OH ) D level &lt; 20ng/ml initially receive load dose 50 000 IU Vitamin D3 weekly 8 week standard clinical practice recommend 2011 Endocrine Society guideline , serum 25 ( OH ) D measure 8 week ensure level 20ng/ml . They undergo 8 week washout period subject receive 25 000 IU Vitamin D3 monthly two month prior randomization . If subject already &gt; 20ng/ml baseline proceed straight randomisation . All subject cease previous counter Vitamin D supplement study start . Thereafter subject block randomize either Vitamin D3 25 000 IU monthly , 50 000 IU monthly 50 000 IU fortnightly oral Cholecalciferol ( Vitamin D3 ) . Serum 25 ( OH ) D , calcium , phosphate , iPTH serum albumin measure 8 , 16 24 week . At 24 week , 24 hour urine calcium measure . Any concomitant medication adverse event record every study visit 4 weekly interval . All subject assign receive 1g calcium carbonate daily . Oral Cholecalciferol ( powder ) ingest direct supervision study visit . Each dose Cholecalciferol dilute 10 mls water . The Cholecalciferol use study formulate spray dry powder stabilize DL-alpha tocopherol ( dry vitamin D3 100 SD/S ) ( DSM Nutritional Products Switzerland Ltd ) .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1 . Post menopausal osteoporosis woman receive treatment Osteoporosis Clinic , University Malaya Medical Centre , Kuala Lumpur . 2 . Resident Malaysia , South Indian descent Muslim Malay wear headscarf 3 . Baseline serum 25 ( OH ) D level &gt; 20 ng/ml 1 . Secondary osteoporosis e.g . glucocorticoid induce osteoporosis 2 . Metabolic bone disease e.g . hypercalcaemia , primary hyperparathyroidism , hyperthyroidism , hypothyroidism , Paget 's disease 3 . Medications interfere bone / vitamin D metabolism e.g . recombinant human parathyroid hormone i.e . Teriparatide , hormone replacement therapy ( HRT ) , glucocorticoid , rifampicin anticonvulsant 4 . Calculated Creatinine Clearance &lt; 60 mls/min 5 . Liver disease Malabsorptive Diseases e.g . celiac disease , radiation , enteritis , active inflammatory bowel disease 6 . Malignancy</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Vitamin D Deficiency</keyword>
</DOC>